ASP Isotopes (NASDAQ:ASPI) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of ASP Isotopes (NASDAQ:ASPI) from a strong sell rating to a sell rating in a research report sent to investors on Saturday.

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of ASP Isotopes in a research note on Wednesday, June 24th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $13.00.

ASP Isotopes Stock Down 2.7%

ASPI stock opened at $3.89 on Friday. The company has a 50 day moving average price of $4.89 and a two-hundred day moving average price of $5.29. The company has a debt-to-equity ratio of 0.76, a quick ratio of 3.85 and a current ratio of 3.87. The stock has a market capitalization of $596.37 million, a P/E ratio of -2.95 and a beta of 3.61. ASP Isotopes has a one year low of $3.51 and a one year high of $14.49.

ASP Isotopes (NASDAQ:ASPI) last issued its quarterly earnings results on Friday, August 14th. The company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.11). ASP Isotopes had a negative return on equity of 64.99% and a negative net margin of 427.98%.The business had revenue of $5.12 million for the quarter, compared to analysts’ expectations of $4.47 million.

Insider Activity at ASP Isotopes

In related news, CFO Heather Kiessling sold 23,124 shares of the stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $6.28, for a total value of $145,218.72. Following the transaction, the chief financial officer directly owned 1,526,252 shares of the company’s stock, valued at approximately $9,584,862.56. This trade represents a 1.49% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Paul Elliot Mann sold 83,759 shares of ASP Isotopes stock in a transaction on Wednesday, June 3rd. The shares were sold at an average price of $7.76, for a total value of $649,969.84. Following the completion of the transaction, the chief executive officer owned 9,579,845 shares in the company, valued at $74,339,597.20. The trade was a 0.87% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders sold 279,079 shares of company stock worth $2,049,208. 14.40% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On ASP Isotopes

Several institutional investors and hedge funds have recently added to or reduced their stakes in ASPI. HITE Hedge Asset Management LLC acquired a new stake in ASP Isotopes in the 4th quarter valued at $2,407,000. Encompass Capital Advisors LLC acquired a new position in shares of ASP Isotopes during the first quarter worth about $30,551,000. SBI Securities Co. Ltd. boosted its position in shares of ASP Isotopes by 196.2% in the fourth quarter. SBI Securities Co. Ltd. now owns 152,120 shares of the company’s stock worth $814,000 after buying an additional 100,769 shares during the period. WIM INVESTMENT MANAGEMENT Ltd purchased a new stake in shares of ASP Isotopes in the fourth quarter worth about $3,217,000. Finally, Sara Bay Financial purchased a new stake in shares of ASP Isotopes in the first quarter worth about $2,593,000. 16.80% of the stock is currently owned by institutional investors and hedge funds.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.